Skip to main content
Equibles
KLRS logo

KLRS · Kalaris Therapeutics, Inc. · Analyst Estimates

Track KLRS — free

Use KLRS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KLRS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.38 +0.08 (+2.42%) At close · Sep 11
Rebalance outlook locked
Market Cap
$80.46M
Shares
23.80M

Analyst Estimates

Compare analyst forecasts for Kalaris Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1754068 CUSIP 482929106 13F (30d) 23 filings 23 filers Visit website Investor relations